Astra Plots Post-Covid Future With $39 Billion Alexion Deal

...rtfolio of Cambridge, U.K.-based AstraZeneca, which had spent years paring away older and less profitable ... Pascal Soriot The purchase is “an important step in the history of the company,” Soriot said on a call with re...
Read Full Article